Leadership Overview
Curia has 8 executives leading key functions including strategy, operations, information technology, human resources, finance, research and development, and drug product manufacturing.
Driven by a commitment to advancing pharmaceutical innovation, Curia provides comprehensive solutions from discovery through commercialization, impacting global health outcomes.
Driven by a commitment to advancing pharmaceutical innovation, Curia provides comprehensive solutions from discovery through commercialization, impacting global health outcomes.
Leadership Roles at Curia
Sam Yasine - Chief Executive Officer
Sam Yasine, the Chief Executive Officer at Curia, directs the company's overarching strategy and operational execution. This leadership role involves guiding the organization's expansion and ensuring alignment with its mission to serve pharmaceutical and biopharmaceutical clients. Yasine oversees the integration of research, development, and manufacturing capabilities, driving efficiency and innovation across all business units. The Chief Executive Officer's focus remains on enhancing Curia's market position as a premier contract research, development, and manufacturing organization. Sam Yasine ensures that the company's strategic objectives translate into tangible results, fostering a culture of scientific excellence and client collaboration. This executive's purview encompasses global operations, aiming to deliver value and advance therapeutic solutions for customers worldwide.
Alex Milenkovic - Founder & Chief Executive Officer
Alex Milenkovic, the Founder & Chief Executive Officer at Curia, established the company's foundational vision and continues to shape its strategic direction. This leadership position involves setting the long-term goals for Curia, emphasizing its role as a contract research, development, and manufacturing organization. Milenkovic's influence extends to fostering innovation and ensuring the company's services meet the evolving needs of pharmaceutical and biopharmaceutical customers. The Founder & Chief Executive Officer's responsibilities include driving growth and maintaining the company's commitment to scientific rigor and client success. Alex Milenkovic's ongoing involvement ensures the company's core values are upheld while pursuing new opportunities for expansion and service enhancement. This executive's strategic oversight is critical to Curia's sustained impact in the industry.
Gerald Auer - Group Chief Financial Officer
Gerald Auer, the Group Chief Financial Officer at Curia, oversees the company's comprehensive financial strategy and fiscal operations. This executive position is central to managing Curia's financial health, ensuring robust capital allocation and driving profitable growth across its contract research, development, and manufacturing services. Auer directs financial planning, analysis, reporting, and treasury functions, providing critical insights to support strategic decision-making for pharmaceutical and biopharmaceutical clients. The Group Chief Financial Officer's responsibilities include optimizing financial performance, managing risk, and ensuring compliance with global financial regulations. Gerald Auer's leadership ensures the financial stability and strategic resource deployment necessary for Curia to expand its capabilities and maintain its competitive edge in the market.
James Grabowski - President, Research & Development
James Grabowski, the President, Research & Development at Curia, leads the company's extensive research and early-stage development initiatives. This senior leadership role is fundamental to Curia's identity as a contract research organization, driving scientific innovation and the discovery of novel therapeutic candidates for pharmaceutical and biopharmaceutical partners. Grabowski oversees all R&D operations, including chemistry, biology, and analytical services, ensuring the highest standards of scientific rigor and project execution. The President, Research & Development's focus is on advancing client projects from concept through preclinical stages, fostering a collaborative environment for scientific breakthroughs. James Grabowski's expertise is critical in guiding the company's scientific strategy and expanding its service offerings to meet the evolving needs of the drug development pipeline.
Ronald Aungst - President, Drug Product
Ronald Aungst, the President, Drug Product at Curia, directs the company's comprehensive drug product development and manufacturing services. This executive leadership position is vital for translating scientific discoveries into viable pharmaceutical formulations and commercial-scale production for clients. Aungst oversees all aspects of drug product operations, including formulation development, analytical testing, and sterile fill-finish manufacturing, ensuring adherence to stringent quality and regulatory standards. The President, Drug Product's strategic mandate involves enhancing Curia's capabilities in delivering complex dosage forms and supporting clients through clinical trials and commercial launch. Ronald Aungst's leadership ensures the seamless integration of R&D insights with manufacturing excellence, solidifying Curia's position as a full-service partner in the pharmaceutical industry.
Kourtney Forster - President
Kourtney Forster, the President at Curia, drives strategic initiatives and operational excellence across key business segments. This leadership role involves overseeing critical functions that support Curia's mission as a leading contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical customers. Forster focuses on enhancing service delivery, optimizing operational workflows, and fostering strong client relationships to ensure the successful progression of projects from discovery through commercialization. The President's responsibilities include ensuring cross-functional alignment and driving efficiency gains throughout the organization. Kourtney Forster's strategic oversight contributes significantly to Curia's ability to adapt to market dynamics and deliver consistent value to its global client base.
Gregory Kuzma - Senior Vice President, Chief Information Officer
Gregory Kuzma, the Senior Vice President, Chief Information Officer at Curia, architects and manages the company's global information technology infrastructure. This critical role involves ensuring the security, reliability, and scalability of all digital systems that support Curia's contract research, development, and manufacturing operations. Kuzma oversees the implementation of advanced technological solutions to enhance operational efficiency and data integrity for pharmaceutical and biopharmaceutical clients. The Chief Information Officer's strategic focus includes driving digital transformation initiatives and safeguarding sensitive intellectual property. Gregory Kuzma's leadership ensures that Curia leverages cutting-edge technology to streamline R&D processes and optimize manufacturing workflows, thereby supporting client objectives and the company's overall growth strategy.
Joseph Sangregorio - Chief Human Resources Officer
Joseph Sangregorio, the Chief Human Resources Officer at Curia, directs all aspects of human capital management and organizational development. This executive role is pivotal in cultivating a high-performance culture that supports Curia's mission as a leading contract research, development, and manufacturing organization. Sangregorio oversees talent acquisition, employee engagement, and professional development programs designed to attract and retain top scientific and operational talent. The Chief Human Resources Officer's strategic initiatives focus on aligning HR policies with business objectives, ensuring a robust workforce capable of meeting the complex demands of the pharmaceutical and biopharmaceutical sectors. Joseph Sangregorio's leadership fosters an environment where employees can thrive, contributing directly to the company's ability to deliver exceptional service and innovation to its clients.
Explore Leadership Teams in Manufacturing
Integrace Health is a therapy-focused healthcare company based in India, specializing in innovative solutions for Musculoskeletal Disorders, Pain Management, and Women's Health. Founded in 2018, it has quickly risen to become one of India's top 70 pharmaceutical companies, with five brands ranked #1 in their respective therapy areas. The company aims to significantly impact the health and well-being of the Indian population and envisions becoming a transformative force in the healthcare landscape by 2030. Integrace Health is committed to innovation, disciplined execution, and inspiring collaboration among its stakeholders.
Company Leadership KR
SS
AA
AN
Unither Pharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in the production of single-dose liquid pharmaceuticals and sterile unit-dose formats for the pharmaceutical and consumer healthcare industries. The company is recognized as a world leader in blow-fill-seal technology, an advanced aseptic manufacturing process that forms, fills, and seals plastic containers in a continuous automated operation, ensuring high levels of sterility and product integrity. Unither's expertise encompasses the development and manufacturing of various liquid dosage forms including oral solutions, suspensions, nasal sprays, eye drops, and other sterile and non-sterile pharmaceutical products delivered in innovative single-dose formats. The company serves a diverse client base of pharmaceutical companies, biotechnology firms, and consumer health brands, providing comprehensive services from formulation development and clinical trial manufacturing to commercial-scale production and packaging. With manufacturing facilities strategically located across multiple continents including Europe and North America, Unither maintains strict quality standards and regulatory compliance with international pharmaceutical guidelines including FDA and EMA requirements. The company emphasizes innovation in drug delivery systems, patient convenience, and sustainability while helping clients bring their pharmaceutical products to market efficiently through its specialized manufacturing capabilities and technical expertise in unit-dose liquid formulations.
Company Leadership
ML
JK
GG
Founded in 1973 and headquartered in Bangalore, India, Micro Lab is a pharmaceutical manufacturer, wholesaler, and R&D company.
Company Leadership MH
RK
RB
PM
Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes. We have a drive and a desire to improve the world around us and make a meaningful difference in the lives of patients, families, communities, and society. (Nasdaq: PCRX) is a provider of non-opioid pain management and regenerative health solutions manufacturing.
Company Leadership
Frequently Asked Questions Regarding Curia Top Executives and Leadership Team
